NMS·Healthcare·$874M·#488 / 520 in Healthcare
ABSI Absci Corporation
18CRITICAL
CATEGORY BREAKDOWN
GROWTH0
QUALITY0
STABILITY35
VALUATION0
GOVERNANCE50
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-38.2%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
3 months
4
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
2.8%
98
< 25% strong
Price / Sales
Market cap relative to trailing revenue
312.0x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-4517
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
13.1%
71
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+21.9%
8
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ABSI WITH…
OR QUICK-COMPARE SECTOR PEERS
RELATED RESEARCH
4 Best Small-Cap AI Drug Discovery Stocks — May 2026May 4, 2026SCORE ALERT
Get notified when ABSI's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.